Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
2012-003644-71Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Dec 2012
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Started Dec 2012; status: terminated.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-003644-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003644-71.